Hyperuricemia as cardiovascular and renal risk factor;La hiperuricemia como factor de riesgo cardiovascular y renal

Dialisis y Trasplante

Volumn 32, Issue 2, 2011, Pages 57-61

  Minguela Pesquera, José Ignacio ^a   Hernando Rubio, Ainhoa ^a   Gallardo Ruiz, Isabel ^a   Martínez Fernández, Isabel ^a   García Ledesma, Paula ^a   Muñoz González, Rosa Inés ^a   Cornago Delgado, Iñaki ^a   Romero Ruiz, Marco Antonio ^a   Montenegro Martínez, Jesús ^a  

^a HOSPITAL DE GALDAKAO   (Spain)

Author keywords

Allopurinol; Cardiovascular risk; Chronic kidney disease; Endothelial damage; Hyperuricemia; Renal transplant

Indexed keywords

ALLOPURINOL;

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERURICEMIA; KIDNEY FUNCTION; PATHOGENESIS;

EID: 79955606540     PISSN: 18862845     EISSN: 18867278     Source Type: Journal    
DOI: 10.1016/j.dialis.2011.03.002     Document Type: Short Survey

References (31)

1. N.L. Edwards The role of hyperuricemia in vascular disorders Curr Opin Rheumatol. 21 2009 132 137
2. T. Ohta, T. Sakano, T. Igarashi, N. Itami, T. Ogawa members of the ARF Associated with Renal Hypouricemia Research Group Exercise-induced acute renal failure associated with renal hypouricaemia: results of a questionnaire-based survey in Japan Nephrol Dial Transplant. 19 2004 1447 1453 (Pubitemid 38786738)
3. G. Remuzzi, N. Perico, and M.E. De Broe Tubulointerstitial diseases B.M. Brenner, Brenner& Rector's. The Kidney 8th edition. 2008 Saunders - Elsevier Philadelphia 1174 1202
4. O.W. Moe Posing the question again: does chronic uric acid nephropathy exist? J Am Soc Nephrol. 21 2010 395 397
5. S. García de Vinuesa Factores de progresión de la enfermedad renal crónica. Prevención secundaria Nefrología. 28 Suppl 3 2008 17 21
6. C.Y. Hsu, C. Iribarren, C.E. McCulloch, J. Darbinian, and A.S. Go Risk factors for end-stage renal disease Arch Intern Med. 169 2009 342 350
7. K. Iseki, Y. Ikemiya, T. Inoue, C. Iseki, K. Kinjo, and S. Takishita Significance of hiperuricemia as a risk factor for developing ESRD in a screened cohort Am J Kidney Dis. 44 2004 642 650 (Pubitemid 39237608)
8. R.P. Obermayr, C. Temml, G. Gutjahr, M. Knechtelsdorfer, R. Oberbauer, and R. Klauser-Braun Elevated uric acid increases the risk for kidney disease J Am Soc Nephrol. 19 2008 2407 2413
9. M. Chonchol, M.G. Shlipak, R. Katz, M.J. Samak, A.B. Newman, and D.S. Siscovick Relationship of uric acid with progression of kidney disease Am J Kidney Dis. 50 2007 239 247 (Pubitemid 47095076)
10. J. Syrjänen, J. Mustonen, and A. Pasternack Hypertryglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy Nephrol Dial Transplant. 15 2000 34 42 (Pubitemid 30037928)
11. E. Akalin, S.V. Ganeshan, J. Winston, and P. Muntner Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy Transplantation. 86 2008 652 658
12. A. Akgul, A. Bilgic, A. Ibis, F.N. Ozdemir, Z. Arat, and M. Haberal Is uric acid a predictive factor for graft dysfunction in renal transplant? Transplant Proceed. 39 2007 1023 1026 (Pubitemid 46764870)
13. S.I. Min, I.J. Yun, Y.J. Kang, Y.J. Park, S.K. Min, and C. Ahn Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome Nephrol Dial Transplant. 24 2009 2584 2590
14. F. Caravaca, M.V. Martín, S. Barroso, B. Cancho, M. Arrobas, and E. Luna Niveles de ácido úrico y proteína C reactiva en pacientes con insuficiencia renal crónica Nefrología. 25 2005 645 654
15. Z. Tang, L.T. Cheng, H.Y. Li, and T. Wang Serum uric acid and endothelial dysfunction in continuous ambulatory peritoneal dialysis patients Am J Nephrol. 29 2009 368 373
16. J. George, E. Carr, J. Davies, J.J.F. Belch, and A. Struthers High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid Circulation. 114 2006 2508 2516 (Pubitemid 44901524)
17. T.S. Perlstein, O. Gumieniak, G.H. Williams, D. Sparrow, P.S. Vokonas, and M. Gaziano Uric Acid and the Development of Hypertension - The Normative Aging Study Hypertension. 48 2006 1031 1036 (Pubitemid 44772704)
18. P.B. Mellen, A.J. Bleyer, T.P. Erlinger, G.W. Evans, F.J. Nieto, and L.E. Wagenknecht Serum Uric Acid Predicts Incident Hypertension in a Biethnic Cohort - The Atherosclerosis Risk in Communities Study Hypertension. 48 2006 1037 1042 (Pubitemid 44772705)
19. M.J. Bos, P.J. Koudstaal, A. Hofman, J.C.M. Witteman, and M.M.B. Breteler Uric Acid Is a Risk Factor for Myocardial Infarction and Stroke - The Rotterdam Study Stroke. 37 2006 1503 1507 (Pubitemid 44305733)
20. D.E. Weiner, H. Tighiouart, E.F. Elsayed, J.L. Griffith, D.N. Salem, and A.S. Levey The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD Am J Kidney Dis. 51 2008 212 223
21. Wiik BP, Larstorp ACK, Høieggen A, Kjeldsen SE, Olsen MH, Ibsen H, et al. Serum uric acid is associated with new onset diabetes in hypertensive patients with left ventricular hypertrophy. The LIFE study. Am J Hypertens. 2010;23:845-51.
22. M. Madero, M.J. Sarnak, X. Wang, T. Greene, G.J. Beck, and J.W. Kusek Uric acid and long-term outcomes in CKD Am J Kidney Dis. 53 2009 796 803
23. E. Krishnan, K. Svendsen, J.D. Neaton, G. Grandits, L.H. Kuller for the MRFIT Research Group Long-term cardiovascular mortality among middle-aged men with gout Arch Intern Med. 168 2008 1104 1110 (Pubitemid 351749228)
24. E. Rodilla, F. Pérez-Lahiguera, J.A. Costa, C. González, A. Miralles, and D. Moral Asociación entre el ácido úrico y el síndrome metabólico con la presencia de microalbuminuria en hipertensos no tratados Med Clin (Barc). 132 2009 1 6
25. F. Viazzi, G. Leoncini, E. Ratto, V. Falqui, A. Parodi, and N. Conti Mild hyperuricemia and subclinical renal damage in untreated primary hypertension Am J Hypertens. 20 2007 1276 1282 (Pubitemid 350151695)
26. E. Fels, and J.S. Sundy Refractory gout: what is it and what to do about it? Curr Opin Rheumatol. 20 2008 198 202 (Pubitemid 351339893)
27. Y.P. Siu, K.T. Leung, M.K.H. Tong, and T.H. Kwan Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level Am J Kidney Dis. 47 2005 51 59
28. D.I. Feig, B. Soletsky, and R.J. Johnson Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension. A randomized trial JAMA. 300 2008 924 932
29. A.J. Luk, G.P. Levin, E.E. Moore, X.H. Zhou, B.R. Kestenbaum, and H.K. Choi Allopurinol and mortality in hyperuricaemic patients Rheumatology. 48 2009 804 806
30. M. Kanbay, A. Ozkara, Y. Selcoki, B. Isik, F. Turgut, and N. Bavbek Effect of treatment of hyperuricemia with alopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions Int Urol Nephrol. 39 2007 1227 1233 (Pubitemid 350193621)
31. M. Goicoechea, S. García de Vinuesa, V. Verdalles, C. Ruiz-Caro, J. Ampuero, and A. Rincón Effect of allopurinol in chronic kidney disease progression and cardiovascular risk Clin J Am Soc Nephrol. 5 2010 1388 1393